MEDISPA.PRO
Ministry of Health code: A06.03.061 Axis M0 · Introductory check-up and longevity biomarkers CEBM: Level A (Functional diagnostics and check-up)

Dual-energy X-ray absorptiometry (DXA)

Dual-Energy X-ray Absorptiometry (DXA)

Industry clinical and economic procedure passport. Full biological mechanism (MoA), patient preparation protocol, first-choice equipment fleet, integration into the resort's master treatment rooms and market price benchmarks.

To the procedure catalogue Equipment fleet Integration treatment rooms Rates and economics
Session duration
20 min
Turnover: ~35 min
Recommended course
1 sessions
1 treatments – an assumption for the economic calculation; the course is prescribed by a physician
Throughput capacity
14 pts
per 8-hour shift
Median rate
3 150 ₽
1 450 ₽ – 5 125 ₽
Course cost
3 150 ₽
at market median
Publication volume
Level A
5 publ. in PubMed

Clinical profile

Measurement of bone mineral density with an X-ray beam at two energies is the gold standard for diagnosing osteoporosis. The USPSTF recommends screening for women aged 65 and over and for postmenopausal women under 65 at increased fracture risk; data on screening men are still limited.

Every statement links to a publication in the list below. This is a snapshot of published research, not a final assessment of the method: international practice and integrated protocols often run ahead of official publications. Draft based on published research; requires review by a physician. Revision: 2026-10-17.

Mechanism of action

  • Dual-energy densitometry is the gold standard for determining bone mineral density. [3]
  • Osteoporosis is diagnosed when femoral neck density is 2.5 standard deviations or more below the mean for young women. [4]

Where studies show an effect

  • Osteoporosis screening in women aged 65 and over and in postmenopausal women under 65 at increased fracture risk. [1]
  • Screening women aged 65+ at high risk produced a small absolute reduction in hip and major osteoporotic fractures. [2]
  • Treatment monitoring: gains in bone density are associated with a greater reduction in the risk of vertebral and hip fractures. [5]

Open questions and study limitations

  • For screening men, data are still insufficient to assess the balance of benefits and harms. [1]
  • There are no studies of screening by bone density alone, nor in men or younger women. [2]
Contraindications. The examination involves a low dose of X-ray radiation; indications and contraindications are determined by a doctor.

Equipment fleet and fit-out

Certified first-choice medical equipment and compatible device systems

Equipment registry
Base configuration (Hero Device)
Dual-energy X-ray bone densitometer

Device platform with proven validation of the biological response. Includes built-in biofeedback sensor systems, patient protection protocols and precision dosing of exposure.

Certification: Russian Ministry of Health registration certificate / CE Medical Device Directive Class IIa/IIb.
Compatible platforms in the MEDISPA.PRO registry
Dual-energy X-ray bone densitometry system
Medical device, Roszdravnadzor registration certificate / CE
In the registry →

Architectural integration and treatment rooms

Resort rooms housing the treatment station (with SanPiN norms and MEP loads)

All treatment rooms →
1.2.4 40.0 m² · Class V

DEXA X-ray diagnostics room

Diagnostic unit (functional, radiology, ultrasound diagnostics) · Equipment: 17 714 900 ₽

Treatment room passport →

Unit economics and resort price benchmarks

Market analysis based on a sample of premium sanatoriums, wellness hotels and preventive medicine clinics

Market price corridor
25th percentile (P25) 1 450 ₽
Market median 3 150 ₽
75th percentile (P75) 5 125 ₽

Median of prices in industry facilities' price lists, 2026

Basis of the price benchmark

Prices for this procedure appear in the price lists of 4 industry facilities; the median and interquartile range across facilities are shown (each facility counts once).

Evidence base

Use for screening is defined by a USPSTF recommendation based on a systematic review.

Publication level A · Plenty of data
  1. 1.
    Screening for Osteoporosis to Prevent Fractures: US Preventive Services Task Force Recommendation Statement.
    JAMA, 2025 · USPSTF recommendation · PMID 39808425
    Osteoporosis screening: women 65+ and postmenopausal women under 65 at increased risk (grade B recommendation); men: insufficient data.
  2. 2.
    Screening for Osteoporosis to Prevent Fractures: A Systematic Evidence Review for the US Preventive Services Task Force.
    JAMA, 2025 · Systematic review for the USPSTF · PMID 39808441
    Screening women aged 65+ at high risk produced a small absolute reduction in hip and major fractures.
  3. 3.
    Update on Osteoporosis Screening and Management.
    Med Clin North Am, 2021 · Review · PMID 34688418
    Dual-energy densitometry is the gold standard for measuring bone mineral density.
  4. 4.
    A reference standard for the description of osteoporosis.
    Bone, 2008 · Review · PMID 18180210
    Osteoporosis is defined as femoral neck density 2.5 SD or more below the young female mean.
  5. 5.
    Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials.
    J Bone Miner Res, 2019 · Meta-regression of RCTs · PMID 30674078
    The greater the gain in bone density on treatment, the greater the reduction in the risk of vertebral and hip fractures.

Publications were found in PubMed; titles and journals are given verbatim, conclusions are a brief summary of the abstracts under the conditions of the specific studies. The level shows the volume of published data, not the value of the method: A — Plenty of data: consistent systematic reviews and meta-analyses of RCTs; B — Some data: reviews or several RCTs, results are heterogeneous; C — Little data: single RCTs or controlled studies; D — Scarce data: mainly reviews, observational and experimental studies. The passport is updated as new work is published and with regard to international practice.